Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Therapeutic Innovation & Regulatory Science
|
March 26, 2024
The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data
Kelly H Zou, Chelsea Vigna, Aniketh Talwai, et al.
Clinical Therapeutics
|
August 25, 2005
Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis
John R Wingard, Craig A Wood, Elizabeth Sullivan, et al.
American Journal of Public Health
|
February 27, 2003
Aligning quality for populations and patients: do we know which way to go?
Erica Ilene Lubetkin, Shoshanna Sofaer, Marthe R Gold, et al.
The Milbank Quarterly
|
September 19, 2008
Getting real performance out of pay-for-performance
Sean Nicholson, Mark V Pauly, Anita Ya Jung Wu, et al.
Health Economics
|
March 29, 2002
A general model of the impact of absenteeism on employers and employees
Mark V Pauly, Sean Nicholson, Judy Xu, et al.
The American Journal of Gastroenterology
|
August 23, 2002
Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions
Walter L Straus, Joshua J Ofman, Catherine MacLean, et al.
The American Journal of Managed Care
|
October 25, 2002
Growth in use of lipid-lowering therapies: are we targeting the right patients?
Robert W Dubois, Charles M Alexander, Sally Wade, et al.
The Journal of Rheumatology
|
April 13, 2002
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs
Joshua J Ofman, Catherine H MacLean, Walter L Straus, et al.
The American Journal of Managed Care
|
June 22, 2010
GRACE principles: recognizing high-quality observational studies of comparative effectiveness
Nancy A Dreyer, Sebastian Schneeweiss, Barbara J McNeil, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 14, 2007
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever
John R Wingard, Helen L Leather, Craig A Wood, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Therapeutic Innovation & Regulatory Science
|
March 26, 2024
The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data
Kelly H Zou, Chelsea Vigna, Aniketh Talwai, et al.
Clinical Therapeutics
|
August 25, 2005
Caspofungin versus amphotericin B for candidemia: a pharmacoeconomic analysis
John R Wingard, Craig A Wood, Elizabeth Sullivan, et al.
American Journal of Public Health
|
February 27, 2003
Aligning quality for populations and patients: do we know which way to go?
Erica Ilene Lubetkin, Shoshanna Sofaer, Marthe R Gold, et al.
The Milbank Quarterly
|
September 19, 2008
Getting real performance out of pay-for-performance
Sean Nicholson, Mark V Pauly, Anita Ya Jung Wu, et al.
Health Economics
|
March 29, 2002
A general model of the impact of absenteeism on employers and employees
Mark V Pauly, Sean Nicholson, Judy Xu, et al.
The American Journal of Gastroenterology
|
August 23, 2002
Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions
Walter L Straus, Joshua J Ofman, Catherine MacLean, et al.
The American Journal of Managed Care
|
October 25, 2002
Growth in use of lipid-lowering therapies: are we targeting the right patients?
Robert W Dubois, Charles M Alexander, Sally Wade, et al.
The Journal of Rheumatology
|
April 13, 2002
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs
Joshua J Ofman, Catherine H MacLean, Walter L Straus, et al.
The American Journal of Managed Care
|
June 22, 2010
GRACE principles: recognizing high-quality observational studies of comparative effectiveness
Nancy A Dreyer, Sebastian Schneeweiss, Barbara J McNeil, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 14, 2007
Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever
John R Wingard, Helen L Leather, Craig A Wood, et al.
Page
of 6